Medical Condition News

RSS

Frisbie Memorial Hospital now uses low-dose CT scanning for screening colorectal cancer

Frisbie Memorial Hospital is now using low-dose CT scanning as a follow-up tool for screening colorectal cancer. This procedure, known as virtual colonoscopy, does not replace the effective and most reliable colorectal cancer screening tool, which is the colonoscopy, but rather it is utilized as a means to obtain additional images of the colon and rectum.

4 Jun 2015

Pivotal Therapeutics enrolls first patient in POMEGA Phase IIa clinical trial of PVT-100

Pivotal Therapeutics Inc., a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announced today the enrollment of the first patient in Pivotal's POMEGA Phase IIa clinical trial with PVT-100.

4 Jun 2015

Dexcom® announces follow App is now available for Android devices

Continuous glucose monitoring is considered the most significant breakthrough in diabetes management in the past 40 years...

4 Jun 2015

Two in one to break cycle of poor diabetes management

Now final-year design student Oscar Daws from Brunel University London has come up with a streamlined device which has been selected for a prestigious exhibition on London’s South Bank and aims to vastly improve patients’ self-management of the disease...

4 Jun 2015

Cytokinetics, The ALS Association expand partnership to fight against ALS

Cytokinetics, Incorporated and The ALS Association announced an expanded partnership in which the company will provide Gold Level Sponsorship of the National Walks to Defeat ALS as well as Platinum Level Sponsorship for ALS Association Golden West Chapter initiatives.

4 Jun 2015

Rhythm announces initiation of two setmelanotide Phase 2 trials for treatment of PWS, POMC-null obesity

Rhythm announced today the initiation of two Phase 2 clinical trials focused on evaluating the safety and effectiveness of setmelanotide (RM-493), the company's novel melanocortin 4 receptor (MC4R) agonist, for the treatment of Prader-Willi Syndrome (PWS) and POMC-null obesity.

4 Jun 2015

Regulus Therapeutics begins RG-012 Phase I clinical study for treatment of Alport syndrome

Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today that dosing has begun in a first-in-human Phase I clinical study of RG-012, a single stranded, chemically modified oligonucleotide that binds to and inhibits the function of microRNA-21 ("miR-21").

4 Jun 2015

CASI files application with CFDA to conduct ENMD-2076 Phase 2 trial in fibrolamellar carcinoma patients

CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China, announced today that it has filed an application with China's Food and Drug Administration to conduct a Phase 2 clinical trial in fibrolamellar carcinoma (FLC) patients in China for its proprietary drug candidate, ENMD-2076.

4 Jun 2015

Profil Institute for Clinical Research forms strategic partnership with Gubra

Profil Institute for Clinical Research, an clinical research organization (CRO) focused on diabetes, obesity and NAFLD/NASH, announced today a strategic collaboration with Gubra ApS, a metabolic preclinical and drug discovery company, to combine expertise and resources to discover and translate into clinical research novel drug targets, compounds and biomarkers addressing metabolic disease.

4 Jun 2015

Egalet announces top-line results from Egalet-002 study in moderate drinkers

Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative pain treatments, today announced top-line results from a randomized, four-way crossover alcohol-interaction study in healthy male and female moderate drinkers with Egalet-002, an abuse-deterrent, extended-release, oral oxycodone-based product in development for the management of pain severe enough to require daily, around-the-clock opioid treatment and for which alternative treatments are inadequate.

4 Jun 2015

Experimental Zephyr endobronchial valve provides good result in emphysema patient at UAB

In late March, physicians at the University of Alabama at Birmingham carefully threaded a one-way valve the size of a black-eyed pea into the lower lobe of Dennis Bullock's left lung. Bullock, a 67-year-old emphysema patient, was the fourth person at UAB to receive the experimental Zephyr endobronchial valve.

4 Jun 2015

Using technology to protect diabetics from foot amputations: an interview with Heleen Kist, HCi Viocare

When people don’t receive the body’s natural signals due to neuropathy, they can unknowingly be exposing their feet to conditions that are known to cause foot ulcers, such as repeated pressure and shear...

4 Jun 2015

Low-cost, non-profit weight loss program offers long-term results

As America's obesity epidemic continues to grow, a new study from the University of Colorado Anschutz Medical Campus shows that a low-cost, non-profit weight loss program offers the kind of long-term results that often elude dieters.

4 Jun 2015

Understanding link between polycystic ovary syndrome and diabetes

Nearly 50 percent of women with polycystic ovary syndrome (PCOS) develop pre-diabetes or type 2 diabetes before the age of 40, but the reasons for the correlation was unclear. In a new study in the American Journal of Physiology-Endocrinology and Metabolism, researchers report that inflammation is the cause for the increased diabetes risk in women with PCOS.

4 Jun 2015

Keeping blood sugar levels under control can help protect hearts from diabetes-related damage

Day in and day out, for years on end, millions of people with diabetes prick their fingers to test their blood sugar level. And many may wonder if all the careful eating, exercise and medication it takes to keep those levels under control is really worth it.

4 Jun 2015

Delirium in ICU associated with lengthier hospital stays and greater risk of death

About one-third of patients admitted to an intensive care unit (ICU) will develop delirium, a condition that lengthens hospital stays and substantially increases one's risk of dying in the hospital, according to a new study led by Johns Hopkins Medicine researchers appearing in the British Medical Journal.

4 Jun 2015

Exalenz Bioscience initiates BreathID clinical study to detect primary liver cancer

Exalenz Bioscience, a leader in developing and marketing non-invasive medical devices for diagnosing and monitoring a range of gastrointestinal and liver diseases, today announced the initiation of a clinical study designed to investigate its BreathID test to non-invasively detect primary liver cancer, also known as Hepatocellular Carcinoma (HCC).

4 Jun 2015

Re-Inflating balloon after carotid stenting appears to double risk of stroke and death

Patients with severe blockages typically undergo surgery to scrape off the fatty deposits from the walls of the vessel, the preferred approach that carries notably lower stroke risk but is not recommended for people too sick to withstand traditional surgery...

4 Jun 2015

New study reports that poor sleep habits increase pain in knee OA

A new study reports that patients with knee osteoarthritis (OA) who have poor sleep habits display greater central sensitization--an amplification of clinical pain. Findings published in Arthritis Care & Research, a journal of the American College of Rheumatology, further show OA patients who catastrophize--consumed by thoughts of pain--had increased central sensitization that was associated with greater clinical pain.

4 Jun 2015

Investigators patent novel technique for detecting carcinomas in oral mucosa

Malignant tumours of the oral cavity are the sixth leading cause of cancer-related deaths worldwide. As such, a fast and accurate diagnosis is key to maximising the probability of successful treatment and the hope and quality of life of patients.

4 Jun 2015

Medical Condition News

Frisbie Memorial Hospital now uses low-dose CT scanning for screening colorectal cancer

Pivotal Therapeutics enrolls first patient in POMEGA Phase IIa clinical trial of PVT-100

Dexcom® announces follow App is now available for Android devices

Two in one to break cycle of poor diabetes management

Cytokinetics, The ALS Association expand partnership to fight against ALS

Rhythm announces initiation of two setmelanotide Phase 2 trials for treatment of PWS, POMC-null obesity

Regulus Therapeutics begins RG-012 Phase I clinical study for treatment of Alport syndrome

CASI files application with CFDA to conduct ENMD-2076 Phase 2 trial in fibrolamellar carcinoma patients

Profil Institute for Clinical Research forms strategic partnership with Gubra

Egalet announces top-line results from Egalet-002 study in moderate drinkers

Experimental Zephyr endobronchial valve provides good result in emphysema patient at UAB

Using technology to protect diabetics from foot amputations: an interview with Heleen Kist, HCi Viocare

Low-cost, non-profit weight loss program offers long-term results

Understanding link between polycystic ovary syndrome and diabetes

Keeping blood sugar levels under control can help protect hearts from diabetes-related damage

Delirium in ICU associated with lengthier hospital stays and greater risk of death

Exalenz Bioscience initiates BreathID clinical study to detect primary liver cancer

Re-Inflating balloon after carotid stenting appears to double risk of stroke and death

New study reports that poor sleep habits increase pain in knee OA

Investigators patent novel technique for detecting carcinomas in oral mucosa

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News